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Background: Management of children with gastroesophageal reflux disease (GORD) and diffi-
cult-to-treat (D-T-T) respiratory symptoms may include double fiberoptic, airway and oesopha-
go-gastro-duodenoscopies (DE). A study was performed to evaluate the usefulness and safety
of DE in children with severe GORD and D-T-T respiratory symptoms.
Methods: A 3-year retrospective review of records of children who underwent DE under
general anaesthesia was performed: the relevant clinical information obtained and the occur-
rence of complications in the 72 h following the DE.
Results: Inflammatory changes of the airways were found at bronchoscopy in 40 out of the 60
children: bronchoalveolar lavage (BAL) demonstrated positive lipid-laden alveolar macro-
phages (LLAM), neutrophilic inflammation or both, respectively in 9, 12 and 16 patients. BAL
bacterial cultures were positive in 2 patients with elevated airway neutrophilia. Structural
airway abnormalities, explaining not GOR-related D-T-T respiratory symptoms were identified
in 11 patients. Oesophagoscopic findings supporting GORD were detected in 32/60 children and
confirmed by consistent histological changes in oesophageal mucosal biopsies (OEB) in 27.
The frequency of complications, all minor, was low during the procedure and in the
following 72 h. They included mild desaturation, stridor or bronchospasm, vomiting, dysphagiaal reflux disease; D-T-T, difficult-to-treat; DE, double fiberoptic, airway and oesophago-gastro-duo-
vage; LLAM, lipid-laden alveolar macrophages; OEB, oesophageal mucosal biopsies; GOR, gastro-
k flow; OGD, oesophago-gastroduodeno; CT, computed tomography; EMLA, eutectic mixture of local
; 1qe3q, first and third quartiles; LRTI, lower respiratory tract infections; ALTE, apparent life-
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594 N. Ullmann et al.and hyperthermia requiring antibiotic treatment in 1 patient. No ‘‘new onset’’ complication
was observed after 48 h following DE. The time-dependent hazard of complications was signif-
icantly higher for patients with a history of onset of respiratory symptoms early in life (2
years of age) (pZ 0.038).
Conclusion: DE can be useful in the clinical evaluation of children with D-T-T respiratory symp-
toms and GORD and is associated with low frequency of mild complications when performed by
appropriately trained and experienced personnel.
ª 2009 Elsevier Ltd. All rights reserved.Introduction
One difficult task in managing children with respiratory
symptoms and gastroesophageal reflux (GOR) is to deter-
mine to what extent GOR is physiologic or constitutes
a pathological condition i.e. a GOR disease (GORD).1e3
Disorders like asthma, airway infections, wheezy bronchitis
and laryngospasm are frequent in children and often
related to a variety of constitutional and/or environmental
factor, rather than to GORD. Moreover, aspirations of
gastric refluxate may occur periodically also in normal
subjects, without inducing clinically relevant respiratory
symptoms.3,4 The presence of GOR is easy to demonstrate
clinically, but a causal relationship with respiratory symp-
toms is often difficult to determine since there are no gold-
standard diagnostic tests to prove the causal relationship.4
In addition, because of the complexity of the interaction
involved and/or difficulties in obtaining satisfactorily
adherence to therapy for a sufficient length of time, life-
style modifications and pharmacologic treatments of GORD
are not always followed by significant improvement in
respiratory symptoms, raising doubt on the link between
the two conditions.4,5
There is a general agreement that surgical options
should be considered in these patients only after failure of
maximal conservative management.6e9 Lack of response to
treatment may require additional investigations, which
include double endoscopy (DE) to detect the presence, type
and the severity of inflammatory changes at the oesopha-
geal and airway levels, but also to exclude anatomic mal-
formations or malfunctions.10,11e13 Ideally, DE should be
performed as a unique procedure, i.e. under the same
general anaesthesia, but data on the clinical value and
feasibility of this procedure in children are scant.10,14
To evaluate the usefulness and safety of DE, a 3-year
retrospective review of records related to children with
severe, difficult-to-treat (D-T-T) respiratory symptoms and
GORD was performed. The clinical information obtained
and the occurrence of complications during the procedure
and in the following 72 h was analyzed.Methods
Patients
Theclinical recordsofchildrenwithchronicor recurrentD-T-T
respiratory symptoms, with a positive 24-h oesophago-gastric
pHmetry, and not responding to standard ‘‘respiratory’’
therapy (bronchodilators, inhaled and systemic steroids,leukotriene modifiers and antibiotics) and ‘‘anti-reflux’’
treatment (lifestyle modifications and pharmacologic treat-
ment) were evaluated. We excluded from the study patients
with: (i) neurological abnormalities and/or dysphagia; (ii)
known structural gastrointestinal abnormalities, such as
pyloric stenosis,malrotationandannularpancreas; (iii) known
motility upper gastrointestinal disorders, such as achalasia
and delayed gastric emptying; (iv) clinical history of primary
aspirationandknownunderlyingheartdisease; (v) recent (less
than four weeks) or current respiratory tract infections.
Clinical assessment
Clinical data were collected uniformly in all children and
included age at onset, type, severity, recurrence and/or
persistency of respiratory symptoms and presence of co-
morbidities. Evaluation of the respiratory impairment
degree was performed by spirometry or expiratory peak
flow (PEF) monitoring, when cooperation of the children
made it possible. Sensitization to the most common classes
of allergens was evaluated by skin prick test (Bayropharm,
Milan, Italy) and specific IgE against the different allergens
tested were determined by solid-phase, chemiluminescent
immunometric assays (Immulite, Medical System; Genoa,
Italy). Specific tests were also performed to identify
conditions such as ciliary dyskinesia, cystic fibrosis and
immunodeficiencies. Suspicion of clinical GORD warranting
investigation by oesophago-gastroduodenoscopy was
determined by the consultant paediatric gastroenterolo-
gists (P.G. or A.B.) based upon: (i) presence of typical
features, (ii) a positive pHmetry and/or barium contrast
fluoroscopy, (iii) severe life-threatening symptoms possibly
related to GOR and/or lack of response to anti-reflux
therapy. The primary indication(s) for DE was recorded by
both the gastroenterologist and the pulmonologist (O.S. or
G.A.R.) performing the procedure and discussed with the
child’s parents, who were informed of the possibility that
new investigation might not lead to a new or a definitive
diagnosis. When clinically indicated, before or after DE,
multidetector computed tomography (CT) was performed
with a 64 slices CT scanner (Siemens Somatom Sensation 64,
Siemens, Erlangen, Germany) with intravenous contrast
agent (Iomeron 300, Bracco, Milano, Italy) to exclude or to
confirm the presence of obliterative bronchiolitis, bron-
chiectasis, airway or pulmonary congenital malformations,
tracheal compression by congenital vascular anomalies.
Written information giving full details about DE, bron-
choalveolar lavage (BAL) and oesophageal mucosal biopsies
(OEB) were given to the parents or tutors. All investigations
were carried out with full-informed written parental
Fiberoptic bronchoscopy and oesophago-gastroduodenoscopy in children 595consent. Access to health records complied with the Italian
legislation.
Double endoscopy
Airways and oesophago-gastroduodeno structures were
examined for anatomic and functional abnormalities, while
BAL and OEB were performed, when clinically indicated and
feasible, to obtain information on the degree and the
characteristics of the inflammatory changes. BAL fluid was
also used for microbiological assays and to evaluate the
lipid-laden alveolar macrophages (LLAM) index, as previ-
ously described,15,16 while OEB to detect the presence of
Helicobacter pylori.17,18
Anaesthesia: DE was performed in theatre, under
general anaesthesia. Salbutamol (5 mg via nebuliser) was
given to patients with reversible airway obstruction, 30 min
before induction of anaesthesia. All patients received
a standard premedication with rectal midazolam (0.5 mg/
kg), and eutectic mixture of local anesthetics (EMLA) cream
was placed in the sites of possible venipuncture. Anaes-
thesia was intravenously induced with propofol (4 mg/kg)
and fentanil (3 mcg/kg), and maintained with sevofluorane
(1.5e2 MAC) in pure oxygen or oxygen/air mixture. Moni-
toring included continuous ECG, oxygen saturation, end-
tidal CO2 and non-invasive blood pressure. Topic anaes-
thesia on larynx and vocal cords was performed using plain
1% lidocaine (maximum dose 1 mg/kg), 2 min before the
beginning of the procedure.
Airway endoscopy: Bronchoscopy was performed in
spontaneously breathing anesthetized patients and venti-
lation was assisted manually, when necessary. 3.8 mm or
4.0 mm external diameter videobronchoscopes (Olympus
BF-3C160 or BF-MP160F, Olympus Corp., New Hyde Park,
NY) were introduced into a nostril through a face mask, as
previously described.16 BAL was performed, with evaluation
of total and differential cell count and of the LLAM index,
and quantitative microbiologic tests for bacteria and
viruses identification undertaken.15,16
Oesophago-gastroduodeno endoscopy (OGD): OGD
endoscopy was performed with Olympus endoscopes (GIF-P
140, GIF-P 160 and XP 160, Olympus Corp., New Hyde Park,
NY) and OEB taken at least 2 cm above the gastroesopha-
geal junction.17 A histological diagnosis of oesophagitis on
OEB was made if at least 2 of the following 3 features were
present: basal cell hyperplasia, increased papillary height,
and epithelial inflammation with eosinophils, neutrophils,
or lymphocytes.17 H. pylori status was detected by
histology of gastric biopsies.18Postoperative care
Vital signs, recovery patterns and complications during and
in the 72 h following DE were prospectively recorded on
data sheets. Patients were firstly observed in the theatre
recovery area for 20 min, with oxygen given by face mask
until fully awake and then observed on the ward for at least
4 h. Oxygen saturation, body temperature, heart rate,
respiratory rate and the presence of any problem were
recorded every 15 min for the first hour, every 30 min for
the next hour and hourly subsequently. Chest radiographywas not routinely performed. Any later complication was
identified from the nursing observation charts and from the
medical notes. Before discharge children were examined by
a clinician and the subsequent management discussed at
outpatient follow-up, on the basis of the whole clinical
evaluation.
Statistical analysis
Descriptive statistics were performed and reported in terms
of absolute frequencies or percentages for qualitative data,
in terms of means with standard deviations (SD) or medians
with first and third quartiles (1qe3q) for quantitative data.
Comparison of frequency distribution was made by means
of the Chi-Square test or the Fisher’s Exact test in case of
expected frequencies less than 5. Bonferroni’s correction
was applied for multiple comparisons. A survival analysis
with the onset of complication as event of interest and time
to complication (in hours) as time variable and onset age of
symptoms (2 years/>2 years) as independent indicator of
risk was performed; the survival curve was drawn with the
Kaplan Meier method and the Log-Rank test was used to
compare the curves. p Values less than 0.05 have been
considered as statistically significant. The software ‘‘Sta-
tistica’’ has been used for all the analyses.Results
Patient demographic and clinical characteristics
Case notes of 60 children (38 males and 22 females, 8.5
months to 17.5 years old) were evaluated. The study pop-
ulation, whose demographic characteristics are summa-
rized in Table 1, was divided into three age groups: (i) group
AZ infants, <2 years old (8 patients); (ii) group BZ pre-
school children, 2 to <6 years old (33 patients); (iii) group
CZ school children, 6 years old (19 patients). As expec-
ted, the frequency of atopy and of symptoms duration >1
year increased with the patient age (pZ 0.004), while the
occurrence of ‘‘early onset respiratory symptoms’’ was
highest in group A (pZ 0.0144).
The most prevalent respiratory conditions present in the
clinical records were: (i) recurrent lower respiratory tract
infections (19 patients), (ii) persistent and/or nocturnal
cough (18 patients), (iii) chronic/recurrent wheeze (13
patients), (iv) ‘difficult-to-treat’ asthma (11 patients), (v)
other symptoms including hoarseness (4 patients), recur-
rent/spasmodic croup (3 patients), apnoea/ALTE (2
patients), recurrent aspiration pneumonia (2 patients)
(Table 2).
Endoscopic, BAL and OEB findings and their clinical
relevance
BAL and OEB were performed respectively in 100% and in
83.3%. The most frequent airway abnormalities detected
were non-specific inflammatory changes, generalized to
the whole respiratory tract (19 patients), or localized to
the larynx and trachea (21 patients). Inflammatory
changes, often associated with the presence of viscous,
Table 1 Demographic and clinical characteristics.
Whole population
(No. 60) No. (%)
Infants (<2 yrs)
(No. 8) No. (%)
Preschool children
(2 to <6 yrs) (No. 33)
No. (%)
Schoolchildren
(6 yrs) (No. 19)
No. (%)
Demographic characteristics
Male gender 38 (63.3) 3 (37.5) 21 (63.6) 14 (73.7)
Prematurity (GA< 37 wks) 14 (23.3) 3 (37.5) 5 (15.2) 6 (31.6)
Atopy 20 (33.3) 0 8 (24.24)a 12 (66.7)b,c
Early onset of respiratory
symptoms (2 yrs)
25 (43.9) 8 (100.0) 21 (63.6) 6 (31.6)b
Symptoms duration
1 yrs 9 (15.8) 4 (80.0) 4 (12.1) 1 (5.3)
>1 yrs 48 (84.2) 1 (20.0) 29 (87.9)a 18 (94.7)b
a p< 0.05, as compared to infants.
b p< 0.01, as compared to infants.
c p< 0.01, as compared to preschool children; GA: gestational age; wks: weeks; yrs:years.
596 N. Ullmann et al.purulent bronchial secretions, were equally distributed in
the 3 age groups, and included mucosal cobble stoning,
erythema, and oedema. Airway abnormalities, not GOR-
related but explaining lack of response to treatment, were
detected in 11 patients and included: (i) vascular
compression of the trachea (in 4 patients, 2 in group A, 1 in
group B and 1 in group C); (ii) vascular compression of the
main left bronchus (in 1 patient in group B); (iii) trache-
oesophageal fistula (2 patients, 1 in group B and 1 in group
C); (iv) palsy vocal cord (in 1 group A patient); (v) lar-
yngomalacia (3 group A patients). BAL analysis demon-
strated: (i) both neutrophilic inflammation (neutrophil
proportion 10% of BAL cells) and positive LLAM index
(20) in 16 patients; (ii) isolated neutrophilia in 12 patients
and (iii) positive LLAM without neutrophilia in 9 patients.
These changes were equally distributed in the 3 age
groups. Positive BAL cultures for Haemophilus influenzae
and Moraxella catarrhalis occurred in 2 patients with
elevated airway neutrophilia (>20% BAL neutrophils), 1 in
group A and 1 in group B. Viral studies were negative in all
the BAL samples, while BAL eosinophilia (3% BAL cells)
was observed in 4 out of the 20 atopic children, 2 in group B
and 2 in group C.
Evidence of reflux on OGD was present in 39 children (4
in group A, 24 in group B and 11 in group C). Oesophago-
scopic findings suggesting GOR-related abnormalities wereTable 2 Indications for double endoscopy in the whole populat
Whole population
(No. 60) No. (%)
Inf
(N
Recurrent LRTI infections 19 (31.7) 4 (
Persistent cough 18 (30.0) 4 (
Chronic wheeze 13 (21.7) 3 (
‘‘Difficult-to-treat’’ asthma 11 (18.3) 1 (
Hoarseness 4 (6.7) 2 (
Recurrent/spasmodic croup 3 (5.0) 1 (
Apnoea/ALTE 2 (3.3) 1 (
Recurrent aspiration pneumonia 2 (3.3) 1 (
LRTIZ Lower respiratory tract infections; ALTEZ apparent life-threadetected in 32/60 patients, equally distributed in the 3
age groups, and included mucosal erythema, oedema,
friability, nodularity, vertical banding, patulous appear-
ance of the oesophageal lumen, and presence of gross
reflux. These findings were confirmed histologically by OEB
analysis in 27 children. OGD endoscopy demonstrated
hiatal hernia in 3 group C patients and oesophageal stric-
ture in 2 patients (1 in group B and 1 in group C). Two
patients in group C had respectively a diagnosis of eosin-
ophilic oesophagitis and of Barrett’s oesophagus. H. pylori
was detected histologically in 2 patients (1 in group B and
1 in group C).
Prevalence, type and severity of complications
Patient characteristics and occurrence of complications
are shown in Fig. 1. There were no major complications.
During the procedure or in the following 4 h, minor
complications included transient mild desaturation in 3
patients, and transient stridor and bronchospasm in 2
patients (Fig. 1a). Neither severe or persistent hypox-
emia, requiring mechanical ventilation, nor apnoea with
or without bradicardia was observed. In the following 24
and 48 h, self-resolving vomiting and dysphagia were
recorded respectively in 2 and 1 patient (Fig. 1b and c).
Body temperature above 38.5 C was detected in 6ion and in each of the three age groups.
ants (<2 yrs)
o. 8) No. (%)
Preschool children
(2 to <6 yrs)
(No. 33) No. (%)
Schoolchildren
(6 yrs) (No. 19)
No. (%)
50.0%) 10 (30.3%) 5 (26.3%)
50.0%) 8 (24.2%) 6 (31.6%)
37.5%) 8 (24.2%) 2 (10.5%)
12.5%) 6 (18.2%) 4 (21.1%)
25.0%) 1 (3.0%) 1 (5.3%)
12.5%) 2 (6.1%) 0 (e)
12.5%) 1 (3.0%) 0 (e)
12.5%) 1 (3.0%) 0 (e)
tening events.
Figure 1 Frequency of ‘still present’ and ‘new onset’ complications at each time point: at endoscopy time or in the following 4 h
(A) and 24 h (B), 48 h (C) and 72 h (D) after DE procedure. Only for patients with complications, name initials, age in years (in
parenthesis), and symptoms are reported as follows in each panel: Panel A: CS (7.32) arterial oxygen desaturation; RA (10.66)
bronchospasm; FF (3.15) arterial oxygen desaturation; SA (2.78) stridor; PG (2.66) arterial oxygen desaturation; Panel B: AA (3.15)
fever; FG (7.05) fever; FL (5.09) fever; RA (2.04) fever; TA (6.44) vomiting; Panel C: FG (7.05) fever; BN (6.74) fever, V; CG (5.29)
fever; GM (1.64) dysphagia; Panel D: FG (7.05) fever.
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evidence of lower respiratory tract infection (Fig. 1b and
c). At 72 h, only 1 out of the 6 patients (FG, 7 years old)
still had hyperthermia associated with clinical signs of
upper respiratory tract infection and was successfully
treated with amoxicillin (Fig. 1d). This patient had
a history of prematurity (<37 weeks) and apnoea in
infancy, was sensitized to house dust mites, was affected
by severe GORD, by recurrent respiratory tract infection
and D-T-T asthma. No differences in gender, gestationalFigure 2 Survival curve of the rate of complications strati-
fied by onset age of symptoms. The follow-up time expressed in
hours is reported on the abscissa whereas the cumulative
proportion surviving is reported on the ordinate. Each ‘new’
onset complication is represented by a grey (patients with
later onset of respiratory symptoms) or black (patients with
early onset of respiratory symptoms) circle.and chronological age, familiar or personal history of
atopy, type of gastroesophageal and respiratory symp-
toms, gastroesophageal and respiratory disease duration
were detected between patients with or without compli-
cations related to DE. However, as compared with
patients without complications, those who developed
complications during the follow-up period were more
likely to have a personal history of ‘‘early onset’’ (2
years of age) respiratory symptoms (44.7% and 76.9% of
the patients, respectively; pZ 0.039). Indeed, performing
a survival analysis, with the onset of complication (as
event of interest), time to complication in hours (as time
variable) and age at onset of symptoms, i.e. 2 years/>2
years (as independent indicator of risk), we found that
early onset versus a later onset of respiratory symptoms
was associated with a significantly higher rate of compli-
cations (Fig. 2) (Log-rank test, pZ 0.038). Indeed, Fig. 2
showed that only 3 infants (grey circles) among 29
patients with later onset of respiratory symptoms (10.3%)
had complications during the follow-up whereas, among
31 patients with early onset of respiratory symptoms, 10
(32.3%) (black circles) had complications during the
follow-up. Moreover, this figure clearly demonstrated the
statistically significant difference between the 2 curves
i.e. patients with later onset of respiratory symptoms
(grey circles) and patients with early onset of respiratory
symptoms (black circles).
Discussion
The present study shows that in infants and children with
D-T-T respiratory symptoms and GORD, a relatively invasive
598 N. Ullmann et al.investigation such as DE may be helpful in establishing
a diagnosis and can be safely performed together by well-
trained teams. Indeed, a significant proportion of the
children evaluated had abnormalities at the airway or at
the GO level, explaining lack of response to anti-GOR
treatment. In addition, DE was associated with a low
prevalence of mild, spontaneously resolving (with one
exception), short-lived complications.
In recent years, the association between GORD and
respiratory disorders has become the focus of intense
study.1e3,10,13e19 However, there is no general consensus on
the most practicable and accurate technique for detecting
a causal relationship between GOR and respiratory symp-
toms and the diagnosis is usually made clinically, some-
times with the support of a pH study, and finally confirmed
by a response of airway symptoms to treatment.20 When no
response to standard anti-reflux therapy is observed,
additional investigations, such as DE, should be performed
to further support or to exclude the diagnosis of GORD-
related respiratory symptoms.16,21 Since the DE is relatively
invasive procedure and involves administration of a general
anaesthetic, it is important to demonstrate its clinical
usefulness and safety.
In the present study DE was helpful in patient manage-
ment and in guiding surgical decisions. In almost 1 out of 5
children structural and functional anomalies of the airways
not GORD-related were detected explaining, at least in part,
some of the D-T-T respiratory symptoms. In agreement with
a previous report,22 the not GORD-related airway abnor-
malities included tracheal and bronchial vascular compres-
sion, tracheoesophageal fistula, palsy vocal cord and
laryngomalacia. In contrast, in over 60% of our patient
population, an abnormal LLAM index and/or a neutrophilic
inflammation were detected, associated with inflammatory
changes of the airways. Although not specific enough to be
diagnostic for GOR-related airway disease, these two BAL
parameters have been previously demonstrated to correlate
with severity indices of GOR.15,16 However, neutrophilic
airway inflammation is a very common finding in a variety of
respiratory disorders and the validation of the presence of
lipid-laden macrophages as a diagnostic tool for aspiration
has been extremely difficult.16 In addition, bacterial growth
associated with BAL neutrophilia was found in 2 patients,
providing information for appropriately guided initiation of
antibiotic treatment, while BAL eosinophilia, showing the
coexistence of an allergic inflammatory reaction, was
detected in 4 out the 20 atopic patients, suggesting the need
for additional anti-inflammatory treatment. Due to the
relatively low number of patients with the different condi-
tions and the ‘‘complexity’’ of their disorders, we could not
find any definitive association between the final diagnosis
and localized v.s. generalized inflammatory changes in the
airway at endoscopy or the predominant respiratory symp-
toms. As an example, hoarseness or recurrent croup were
present in children with laryngomalacia but also with
tracheal compression and GOR.
Abnormal oesophagoscopic findings and a histological
diagnosis of oesophagitis on OEB were reported only in less
than 50% of patients. This is consistent with previous
reports14 and possibly due to high prevalence of weakly
acid refluxes observed in children with respiratory
symptoms.23Finally, as already shown in studies on the safety of
fiberoptic bronchoscopy in children with severe bronchial
obstruction, including those with GOR,12,24 all endoscopies
were performed without major complications.
In conclusion, we have shown that DE under
general anaesthesia is clinical useful in children with GORD
and D-T-T respiratory symptoms and can be performed
safely. However, the findings here presented must not be
taken as being applicable to all children with GORD and
respiratory symptoms, because of some limitations of the
study. Firstly, this was a retrospective analysis on a small,
highly selected group of children who underwent investi-
gation as part of their clinical assessment rather than
according to a strict research protocol. Secondly, these
procedures were performed in a centre with appropriately
trained and experienced personnel. Finally, we have to
recognize that there is always the potential for morbidity,
although limited, when performing these procedures due to
the complexity of the conditions that may be involved in
the pathogenesis of respiratory symptoms in this group of
children.
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